Advertisement

The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

Ischemia Symptoms

Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts

donation on its way

I am sure you had a GREAT vacation, Bobbio. On Feb 23rd,I was in the hospital recovering from a 'TIA,' transientischemic attack. All is well now, my friend. No worries.Donation on its way.#1 fan...
Robert J. Frascino, M.D.

Response from Robert J. Frascino, M.D.

The Robert James Frascino AIDS Foundation
Hey #1 Fan,Sorry to hear about your recent TIA, but encouraged that it was indeed transient and that all is well now. Be sure to have close follow-up with your doctor to decrease the risk of subsequent attacks. Do I need to make a house call?Be... Read more »

Stroke & HIV

On May 8th I had a mini-stroke (TIA) and ended up in the ER. The CT scan (wo contrast) did not show... Read more »

bad reaction to P I's

I am convinced that protease inhibitors make me dizzy and have even caused me to have something... Read more »
Articles
U.S. Centers for Disease Control and Prevention

Official: Over Half a Million Cambodians to be AIDS Victims by 2010

More than half a million Cambodians will either have AIDS or have died of the disease by 2010 in what Tia Phalla, secretary-general of Cambodia's National AIDS Authority, described Sunday as the country's new "killing field." Since the discovery of... Read more »
U.S. Food and Drug Administration

Expanded Indication for Selzentry (maraviroc)

On November 20, 2009, the Food and Drug Administration approved a supplemental NDA to expand the indication for Selzentry (maraviroc) to include combination antiretroviral treatment of therapy naive adults infected with CCR5-tropic HIV-1 virus.... Read more »
U.S. Food and Drug Administration

Traditional Approval and Label Changes for Selzentry (Maraviroc)

On November 25, 2008, FDA granted full, traditional approval for the use of maraviroc in treatment-experienced patients infected with CCR5-tropic HIV-1. The change from accelerated to traditional approval was based on 48 week data from two... Read more »
U.S. Food and Drug Administration

Important Label Update for Norvir (Ritonavir)

On November 23, 2009, FDA approved changes to the Norvir package insert (product label) to include drug-drug interaction information for concurrent ritonavir administration with: inhaled medicines such as salmeterol or salmeterol in combination... Read more »